Delivery Order SPE2DR25D2014-SPE2DR26FA1V9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,932.71 by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 20, 2025, and will be fulfilled at the company's Conshohocken facility. The award represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,732.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pharmaceutical product. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- Amerisourcebergen Drug Corp (subsidiary of parent company Cencora, Inc.) was awarded a $16,824.46 delivery order by the Defense Logistics Agency on January 7, 2026, for REPATHA 140 MG/ML SureClick autoinjector medication. The contract is a firm fixed-price arrangement with no set-aside designation, indicating competitive award, and is scheduled for completion by January 8, 2026. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,087.67 for Repatha 140 mg/ml SureClick auto-injectors on September 25, 2025. This non-compete delivery order, which carries a firm fixed price structure and an ultimate completion date of September 26, 2025, was issued through the Medical Supply Chain, a defense-focused component of federal medical procurement. The contract represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,349.17 by the Defense Logistics Agency on September 9, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is not set-aside and was competitively awarded with a firm fixed price structure and an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,865.12 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor. The contract represents a child...
- On January 7, 2026, the Defense Logistics Agency awarded a $40,985.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This non-set-aside contract is a child order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,857.21 by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 12, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,242.52 by the Defense Logistics Agency on November 13, 2025, for the supply of Repatha 140 mg/mL SureClick medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 14, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,340.28 by the Defense Logistics Agency on August 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 5, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1V9Delivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,164.58 for REPATHA 140 mg/ml SureClick by the Defense Logistics Agency on January 8, 2026. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and was awarded on a competitive basis without set-aside designation. This delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. REPATHA (evolocumab), a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk, represents the type of specialty pharmaceutical product that Amerisourcebergen regularly delivers through its federal contracts. The Defense Logistics Agency's Medical Supply Chain relies on established vendors like Amerisourcebergen to ensure timely procurement of essential medications for military treatment facilities and defense healthcare systems. The parent company, Cencora, Inc., which does business as Amerisourcebergen, holds the underlying indefinite delivery contract and maintains significant federal procurement relationships across multiple agencies, including the Department of Veterans Affairs and Department of Justice.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 1/7/26 |